GlassScriptPhysician profile
Kayley Huffman
NPI 1548938764
$1,440.27
in general payments reported to CMS, 2019-2025
17 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.43 · 2023: $23.14 · 2024: $363 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,425.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $251.34 | 2024-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $223.49 | 2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $193.13 | 2024-2025 | Qelbree |
| Tris Pharma INC | $100.88 | 2024-2025 | Dyanavel Xr, Onyda Xr |
| Collegium Pharmaceutical, INC. | $93.64 | 2025 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $85.34 | 2024 | Austedo Xr |
| Biogen, INC. | $73.42 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $73.25 | 2024-2025 | |
| Corium, LLC | $69.63 | 2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $69.23 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $52.59 | 2023-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.72 | 2025 | Caplyta |
| Myriad Genetic Laboratories, INC. | $37.03 | 2024 | Genesight |
| Lundbeck LLC | $25.09 | 2025 | Rexulti |
| Pfizer INC. | $19.49 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $14.57 | 2024 | |
| Genentech USA, INC. | $14.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayley Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.